51 related articles for article (PubMed ID: 9811053)
1. Monoclonal expansion of synoviocytes in rheumatoid arthritis.
Imamura F; Aono H; Hasunuma T; Sumida T; Tateishi H; Maruo S; Nishioka K
Arthritis Rheum; 1998 Nov; 41(11):1979-86. PubMed ID: 9811053
[TBL] [Abstract][Full Text] [Related]
2. Glycolysis, a driving force of rheumatoid arthritis.
Gan PR; Wu H; Zhu YL; Shu Y; Wei Y
Int Immunopharmacol; 2024 May; 132():111913. PubMed ID: 38603855
[TBL] [Abstract][Full Text] [Related]
3. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies.
Yu EW; Dolter KE; Shao LE; Yu J
Clin Exp Immunol; 1998 Apr; 112(1):126-32. PubMed ID: 9566800
[TBL] [Abstract][Full Text] [Related]
4. Engineering approaches to investigate the roles of lymphatics vessels in rheumatoid arthritis.
Kraus SE; Lee E
Microcirculation; 2023 Apr; 30(2-3):e12769. PubMed ID: 35611452
[TBL] [Abstract][Full Text] [Related]
5. YAP/TAZ: Key Players for Rheumatoid Arthritis Severity by Driving Fibroblast Like Synoviocytes Phenotype and Fibro-Inflammatory Response.
Caire R; Audoux E; Courbon G; Michaud E; Petit C; Dalix E; Chafchafi M; Thomas M; Vanden-Bossche A; Navarro L; Linossier MT; Peyroche S; Guignandon A; Vico L; Paul S; Marotte H
Front Immunol; 2021; 12():791907. PubMed ID: 34956224
[TBL] [Abstract][Full Text] [Related]
6. The Tumor-Like Phenotype of Rheumatoid Synovium: Molecular Profiling and Prospects for Precision Medicine.
You S; Koh JH; Leng L; Kim WU; Bucala R
Arthritis Rheumatol; 2018 May; 70(5):637-652. PubMed ID: 29287304
[TBL] [Abstract][Full Text] [Related]
7. Targeting the programmed cell death-1 pathway in rheumatoid arthritis.
Sandigursky S; Silverman GJ; Mor A
Autoimmun Rev; 2017 Aug; 16(8):767-773. PubMed ID: 28572054
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of matrine derivate MASM in mice with collagen-induced arthritis and on fibroblast-like synoviocytes.
Zou Y; Li Q; Liu D; Li J; Cai Q; Li C; Zhao Q; Xu W
Sci Rep; 2017 May; 7(1):2454. PubMed ID: 28550307
[TBL] [Abstract][Full Text] [Related]
9. Cellular electrophysiological principles that modulate secretion from synovial fibroblasts.
Clark RB; Schmidt TA; Sachse FB; Boyle D; Firestein GS; Giles WR
J Physiol; 2017 Feb; 595(3):635-645. PubMed ID: 27079855
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of smoothened decreases proliferation of synoviocytes in rheumatoid arthritis.
Zhu SL; Huang JL; Peng WX; Wu DC; Luo MQ; Li QX; Li ZX; Feng XX; Liu F; Wang MX; Chen WQ; Olsen N; Zheng SG
Cell Mol Immunol; 2017 Feb; 14(2):214-222. PubMed ID: 26189371
[TBL] [Abstract][Full Text] [Related]
11. Activated protein C inhibits proliferation and tumor necrosis factor α-stimulated activation of p38, c-Jun NH2-terminal kinase (JNK) and Akt in rheumatoid synovial fibroblasts.
Julovi SM; Shen K; Mckelvey K; Minhas N; March L; Jackson CJ
Mol Med; 2013 Oct; 19(1):324-31. PubMed ID: 24096826
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of rheumatoid arthritis fibroblast-like synoviocytes: possible roles of nitric oxide and the thioredoxin 1.
Li H; Wan A
Mediators Inflamm; 2013; 2013():953462. PubMed ID: 23690674
[TBL] [Abstract][Full Text] [Related]
13. CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression.
Lee J; Jeong H; Park EJ; Hwang JW; Huang B; Bae EK; Ahn JK; Cha HS; Koh EM
Rheumatol Int; 2013 Sep; 33(9):2241-8. PubMed ID: 23455633
[TBL] [Abstract][Full Text] [Related]
14. A systems approach to rheumatoid arthritis.
You S; Cho CS; Lee I; Hood L; Hwang D; Kim WU
PLoS One; 2012; 7(12):e51508. PubMed ID: 23240033
[TBL] [Abstract][Full Text] [Related]
15. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors.
Bottini N; Firestein GS
Nat Rev Rheumatol; 2013 Jan; 9(1):24-33. PubMed ID: 23147896
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor as a therapeutic target for systemic autoimmune diseases.
Kameda H; Suzuki M; Takeuchi T
Drug Target Insights; 2007; 2():239-47. PubMed ID: 21901078
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of TPP1 in fibroblast-like synovial cells might be involved in the pathogenesis of rheumatoid arthritis.
Qing YF; Zhou JG; Zhao MC; Xie WG; Yang QB; Xing Y; Zeng SP; Jiang H
Rheumatol Int; 2012 Aug; 32(8):2503-10. PubMed ID: 21833529
[TBL] [Abstract][Full Text] [Related]
18. TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan.
Ciurtin C; Majeed Y; Naylor J; Sukumar P; English AA; Emery P; Beech DJ
BMC Musculoskelet Disord; 2010 Jun; 11():111. PubMed ID: 20525329
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.
Bartok B; Firestein GS
Immunol Rev; 2010 Jan; 233(1):233-55. PubMed ID: 20193003
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis.
Badot V; Galant C; Nzeusseu Toukap A; Theate I; Maudoux AL; Van den Eynde BJ; Durez P; Houssiau FA; Lauwerys BR
Arthritis Res Ther; 2009; 11(2):R57. PubMed ID: 19389237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
